Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01699763 · ClinicalTrials.gov registry record · NA
Evaluation of Blood Glucose Monitoring Systems
A NA study, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
NCT01699763 is a NA study that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 112 participants.
The verdict
NCT01699763, a NA study, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate the performance of a Bayer Blood Glucose Monitoring System (BGMS) and two additional Blood Glucose Monitoring Systems (BGMS) from other companies. All meter BG results were compared with plasma results obtained with a reference laboratory glucose method (YSI Glucose Analyzer).
Interventions
- DEVICE Contour® NEXT LINK BGMS
- DEVICE OneTouch® UltraLink® BGMS
- DEVICE Nova Max Link® BGMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2012-10 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01699763
The ClinicalTrials.gov registry entry for NCT01699763 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Contour® NEXT LINK BGMS is the first listed.
NCT01699763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01699763 about?
NCT01699763 is a clinical study titled "Evaluation of Blood Glucose Monitoring Systems". The purpose of this study was to evaluate the performance of a Bayer Blood Glucose Monitoring System (BGMS) and two additional Blood Glucose Monitoring Systems (BGMS) from other companies. All meter BG results were compared with plasma results obtained with a reference laboratory glucose method (YSI...
What is the current status of trial NCT01699763?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2012-10. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01699763?
The interventions under investigation include: Contour® NEXT LINK BGMS (DEVICE), OneTouch® UltraLink® BGMS (DEVICE), Nova Max Link® BGMS (DEVICE).
Who is sponsoring clinical trial NCT01699763?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.